Academic partner
of Lymphoma
Clinical Research


Collaboration with LYSARC enables lymphoma research stakeholders to benefit from:

  • Professional clinical research services from phase 1 to phase 4
  • A unique expertise in the field of lymphoma: both operational and scientific
  • A strong integration into the academic environment, including close and historical ties with LYSA, leading cooperative group in lymphoma research
  • A scientific focus combined with a long and positive experience of partnership and industrial developments
  • The critical mass of the largest lymphoma clinical research operational organization in Europe
  • An important patient enrolment capacity through LYSA on its own or in cooperation with its foreign partners
  • Access to unparalleled clinical databases and annotated biological collections
  • A stepping stone to other lymphoma research organizations: ELI, The European Lymphoma Institute and CALYM, the consortium for the acceleration of innovation and its transfer in the lymphoma field